At-home colon kit increases screening rates

Share this article:

A pilot study using at-home colon-cancer screening kits boosted the screened patient population by 40%. Kaiser Permanente reported that the National Institutes of Health study included sending at-home fecal analysis tests to 869 community health clinic patients in Portland, OR.

The clinics serve a large number of uninsured Latino patients. The study included patients from three clinics, letters in English and Spanish, and follow-up postcards for patients who did not mail in stool samples for analysis. Some patients received a postcard and a follow-up call if they did not return the testing kits. The control group did not receive a test in the mail or letters, but may have been tested at the clinic.

Kaiser noted that cost often prevents doctors from using preliminary screenings, like the fecal test, among poor, uninsured patients. A positive fecal immunochemical test does require a colonoscopy to rule out cancer.

The Centers for Disease Control found in 2012 that 66% of non-Latino whites were adequately screened for colorectal cancer, compared to 53% of Latinos, Kaiser added.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Business Briefs

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.